Infoteenus
07.080 Bioloogia. Botaanika. Zooloogia
Uued standardid
ISO 16921-2:2026
Biotechnology — Gene delivery systems — Part 2: Quantification methods for viral vectors
Käsitlusala: This document specifies minimum requirements for quantifying viral vectors in terms of physical titer and their associated activity. This document specifies key considerations for quantification methods for viral vector titer as well as activity, including method selection, measurement process, data analysis, and reporting.
Alusdokumendid:
ISO 20012:2026
Biotechnology — Biobanking — Requirements for human natural killer cells derived from pluripotent stem cells
Käsitlusala: This document specifies requirements for the biobanking of human natural killer (NK) cells derived from human pluripotent stem cells (hPSCs), including the requirements for the differentiaton, culture, characterization, quality control, storage, thawing and transport of NK cells.
Requirements for the collection of biological source material, the transport to and reception of biological source material and hPSCs at the biobank, as well as the establishment, expansion and QC of hPSCs are covered in ISO 24603.
This document is applicable to all organizations performing biobanking of human NK cells used for research and development in the life sciences.
This document does not apply to human NK cells for the purpose of in vivo application in humans, clinical applications or therapeutic use.
NOTE International, national or regional regulations or requirements or multiple of them can also apply to specific topics covered in this document.
Requirements for the collection of biological source material, the transport to and reception of biological source material and hPSCs at the biobank, as well as the establishment, expansion and QC of hPSCs are covered in ISO 24603.
This document is applicable to all organizations performing biobanking of human NK cells used for research and development in the life sciences.
This document does not apply to human NK cells for the purpose of in vivo application in humans, clinical applications or therapeutic use.
NOTE International, national or regional regulations or requirements or multiple of them can also apply to specific topics covered in this document.
Alusdokumendid: